TY  - GEN
AU  - Lovell,Daniel J
AU  - Ruperto,Nicolino
AU  - Mouy,Richard
AU  - Paz,Eliana
AU  - Rubio-Pérez,Nadina
AU  - Silva,Clovis A
AU  - Abud-Mendoza,Carlos
AU  - Burgos-Vargas,Ruben
AU  - Gerloni,Valeria
AU  - Melo-Gomes,Jose A
AU  - Saad-Magalhaes,Claudia
AU  - Chavez-Corrales,J
AU  - Huemer,Christian
AU  - Kivitz,Alan
AU  - Blanco,Francisco J
AU  - Foeldvari,Ivan
AU  - Hofer,Michael
AU  - Huppertz,Hans-Iko
AU  - Job Deslandre,Chantal
AU  - Minden,Kirsten
AU  - Punaro,Marilynn
AU  - Block,Alan J
AU  - Giannini,Edward H
AU  - Martini,Alberto
TI  - Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years
SN  - 2326-5205
PY  - 2016///0216
KW  - Abatacept
KW  - adverse effects
KW  - Activities of Daily Living
KW  - psychology
KW  - Adolescent
KW  - Antirheumatic Agents
KW  - Arthritis, Juvenile
KW  - drug therapy
KW  - Child
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Longitudinal Studies
KW  - Male
KW  - Psychology
KW  - Quality of Life
KW  - Self Report
KW  - Surveys and Questionnaires
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/art.39234
ER  -